Stocks and Investing Stocks and Investing
Thu, April 7, 2022
Wed, April 6, 2022
Tue, April 5, 2022
Mon, April 4, 2022

Anupam Rama Maintained (APLS) at Buy with Increased Target to $69 on, Apr 4th, 2022


Published on 2024-10-27 20:17:00 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Increased Target from $66 to $69 on, Apr 4th, 2022.

Anupam has made no other calls on APLS in the last 4 months.



There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Anupam


  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $86 on, Monday, March 7th, 2022
  • Timur Ivannikov of "Raymond James" Maintained at Strong Buy with Increased Target to $114 on, Tuesday, March 1st, 2022
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $112 on, Tuesday, January 11th, 2022
  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $84 on, Wednesday, December 8th, 2021